6.2.8. Liraglutide—Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimer’s Disease (ELAD) Trial. This evidence concerns the gene GLP1R and early-onset autosomal dominant Alzheimer disease.